1981 - Fellow of Alfred P. Sloan Foundation
Thomas P. Davis mainly investigates Blood–brain barrier, Tight junction, Pharmacology, Cell biology and Occludin. The various areas that Thomas P. Davis examines in his Blood–brain barrier study include Endothelial stem cell, Cell junction and Peptide. His Tight junction research includes elements of Hypoxia, Immunology and Pathology.
In general Pharmacology, his work in Morphine is often linked to Glycopeptide linking many areas of study. His Cell biology study combines topics in areas such as Paracellular transport and Calcium flux. His Occludin study incorporates themes from Inflammation, Internal medicine, Endocrinology and Claudin.
His scientific interests lie mostly in Blood–brain barrier, Internal medicine, Pharmacology, Endocrinology and Biochemistry. His Blood–brain barrier research is multidisciplinary, relying on both Occludin, Tight junction, Cell biology and Paracellular transport. Thomas P. Davis interconnects Endothelial stem cell, Hypoxia, Homeostasis, Immunology and Cell junction in the investigation of issues within Tight junction.
His Internal medicine research incorporates themes from In vitro and Oncology. His study in the fields of Morphine under the domain of Pharmacology overlaps with other disciplines such as P-glycoprotein. His work deals with themes such as Neuropeptide, Receptor and Neurotensin, which intersect with Endocrinology.
Thomas P. Davis mostly deals with Blood–brain barrier, Pharmacology, Internal medicine, Central nervous system and Oncology. His studies deal with areas such as Endothelial stem cell, Tight junction, Cell biology and Paracellular transport as well as Blood–brain barrier. His work in Tight junction covers topics such as Homeostasis which are related to areas like Inflammation.
His Pharmacology study combines topics from a wide range of disciplines, such as Cortical spreading depression and Sumatriptan. His Internal medicine study integrates concerns from other disciplines, such as Glembatumumab vedotin, Endocrinology and GPNMB. He has included themes like Traumatic brain injury, Drug delivery, Opioid, Trigeminal nerve and Nasal administration in his Central nervous system study.
Thomas P. Davis focuses on Blood–brain barrier, Pharmacology, Drug delivery, Central nervous system and Cell biology. The study incorporates disciplines such as Morphine, Tight junction, Drug and Amyloid in addition to Blood–brain barrier. His Tight junction research is multidisciplinary, incorporating perspectives in Endothelial stem cell, Oxidative stress, Inflammation and Intracellular.
His work carried out in the field of Drug delivery brings together such families of science as Distribution, Paracellular transport and Drug delivery to the brain. Thomas P. Davis combines subjects such as Psychiatry, Traumatic brain injury and Cerebral hypoxia with his study of Central nervous system. His studies in Cell biology integrate themes in fields like Molecular biology and Growth factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
Brian T. Hawkins;Thomas P. Davis.
Pharmacological Reviews (2005)
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Jason D. Huber;Richard D. Egleton;Thomas P. Davis.
Trends in Neurosciences (2001)
Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma
Kristin Sanderson;Ronald Scotland;Peter Lee;Dongxin Liu.
Journal of Clinical Oncology (2005)
Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation.
Karen S. Mark;Thomas P. Davis.
American Journal of Physiology-heart and Circulatory Physiology (2002)
Strategies to advance translational research into brain barriers
Edward Neuwelt;N Joan Abbott;Lauren Abrey;William A Banks.
Lancet Neurology (2008)
Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke
Rachel C. Brown;Thomas P. Davis.
Vascular dysfunction-The disregarded partner of Alzheimer's disease
Melanie D. Sweeney;Axel Montagne;Abhay P. Sagare;Daniel A. Nation.
Alzheimers & Dementia (2019)
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.
R Polt;F Porreca;L Z Szabò;E J Bilsky.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression
J. D. Huber;K. A. Witt;S. Hom;R. D. Egleton.
American Journal of Physiology-heart and Circulatory Physiology (2001)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar;Mario Sznol;Biwei Zhao;Ding Wang.
Science Translational Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: